ATE257387T1 - Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes - Google Patents

Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes

Info

Publication number
ATE257387T1
ATE257387T1 AT95923374T AT95923374T ATE257387T1 AT E257387 T1 ATE257387 T1 AT E257387T1 AT 95923374 T AT95923374 T AT 95923374T AT 95923374 T AT95923374 T AT 95923374T AT E257387 T1 ATE257387 T1 AT E257387T1
Authority
AT
Austria
Prior art keywords
disorders
pct
brain
phospholipid
abstract
Prior art date
Application number
AT95923374T
Other languages
English (en)
Inventor
Yves Ponroy
Original Assignee
Inst Rech Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9464681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE257387(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inst Rech Biolog Sa filed Critical Inst Rech Biolog Sa
Application granted granted Critical
Publication of ATE257387T1 publication Critical patent/ATE257387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95923374T 1994-06-27 1995-06-13 Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes ATE257387T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9407867A FR2721516B1 (fr) 1994-06-27 1994-06-27 Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
PCT/FR1995/000771 WO1996000077A1 (fr) 1994-06-27 1995-06-13 Nouvelles utilisations d'un complexe a base de phospholipides cerebraux en therapeutique et dans l'alimentation

Publications (1)

Publication Number Publication Date
ATE257387T1 true ATE257387T1 (de) 2004-01-15

Family

ID=9464681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95923374T ATE257387T1 (de) 1994-06-27 1995-06-13 Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes

Country Status (10)

Country Link
US (1) US5853747A (de)
EP (1) EP0719152B2 (de)
JP (1) JPH09502458A (de)
AT (1) ATE257387T1 (de)
AU (1) AU701528B2 (de)
CA (1) CA2170243C (de)
DE (1) DE69532406T2 (de)
ES (1) ES2214503T3 (de)
FR (1) FR2721516B1 (de)
WO (1) WO1996000077A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
FR2736265B1 (fr) * 1995-07-07 1997-09-26 Forgeot Marcel Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives
KR100190826B1 (ko) * 1996-08-26 1999-06-01 강재헌 적혈구 용혈 억제용 약제학적 조성물 및 그의제조방법
FR2762993B1 (fr) * 1997-05-06 1999-08-13 Inst Rech Biolog Sa Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique
US20020192295A1 (en) * 1999-01-14 2002-12-19 Yves Ponroy Novel use of phospholipids of vegetable and animal origin in nutritional therapy
FR2788437B1 (fr) * 1999-01-14 2006-08-11 Inst Rech Biolog Sa Nouvelle utilisation de phospholipides d'origine vegetale et animale en therapeutique nutritionnelle
RU2146933C1 (ru) * 1999-07-01 2000-03-27 Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" Способ профилактики и лечения ишемии миокарда при коронароинвазивных вмешательствах
DE19943198A1 (de) * 1999-09-09 2001-03-15 Meyer Lucas Gmbh & Co Therapeutikum zur Behebung zentralnervöser Funktionsstörungen
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
PT1317272E (pt) * 2000-05-25 2006-06-30 Boehringer Ingelheim Int Composicao para melhoramento da proteccao celular compreendendo um antioxidante lipofilo e um antioxidante hidrofilo
AU2002213143A1 (en) * 2000-10-12 2002-04-22 Institute Of Materials Research And Engineering Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells
CN1477958A (zh) * 2000-10-31 2004-02-25 高露洁-棕榄公司 组合物及方法
RU2192871C2 (ru) * 2000-11-22 2002-11-20 Нижегородское государственное предприятие по производству бактерийных препаратов - ИмБио Способ получения биологически активного комплекса из животного сырья для терапевтического использования
US7048941B2 (en) 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
JP2004026803A (ja) * 2002-03-29 2004-01-29 Nof Corp 神経細胞死予防剤
CN1761736A (zh) * 2003-06-09 2006-04-19 三得利株式会社 油脂臭的新式除臭法及其组合物
WO2007021735A2 (en) * 2005-08-10 2007-02-22 William Llewellyn Use of phospholipid arachidonic acids for increasing muscle mass in humans
FI120720B (fi) * 2006-06-16 2010-02-15 Neurofood Ab Oy Maitopohjaisia elintarvikkeita, jotka sisältävät keskushermoston lipidejä
JP2008214338A (ja) * 2007-02-08 2008-09-18 Shiseido Co Ltd 高次脳機能低下改善剤および遅延記憶低下改善剤
KR101787618B1 (ko) * 2010-09-24 2017-10-18 후지노 브레인 리서치 가부시키가이샤 항중추신경계 염증제
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
NL2012795B1 (en) * 2014-05-09 2016-02-24 Sonac B V Novel hydrolysate.
ES2750308T3 (es) * 2015-05-22 2020-03-25 Bioiberica Proceso para preparar un extracto de cerebro de un animal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5171M (de) * 1966-02-11 1967-06-19
US4385053A (en) * 1981-03-11 1983-05-24 Barry Reisberg Treatment for human memory impairment associated with aging
JPS6229951A (ja) * 1985-07-31 1987-02-07 Showa Yakuhin Kako Kk 脳髄粉末の製造法
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1230141B (it) * 1989-05-03 1991-10-14 Fidia Spa Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
JPH0717855A (ja) * 1992-09-02 1995-01-20 Maruha Corp 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.

Also Published As

Publication number Publication date
CA2170243C (fr) 2005-05-24
JPH09502458A (ja) 1997-03-11
FR2721516B1 (fr) 1996-09-13
CA2170243A1 (fr) 1996-01-04
AU701528B2 (en) 1999-01-28
DE69532406D1 (de) 2004-02-12
FR2721516A1 (fr) 1995-12-29
DE69532406T2 (de) 2004-11-04
EP0719152A1 (de) 1996-07-03
US5853747A (en) 1998-12-29
AU2795395A (en) 1996-01-19
EP0719152B2 (de) 2009-04-08
ES2214503T3 (es) 2004-09-16
EP0719152B1 (de) 2004-01-07
WO1996000077A1 (fr) 1996-01-04

Similar Documents

Publication Publication Date Title
ATE257387T1 (de) Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes
HU9301978D0 (en) Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin
AU6909091A (en) Neurologic agents for nasal administration to the brain
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
GEP20002146B (en) Therapeutic Peptide Derivatives
WO2004001383A3 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
ZA951505B (en) Fatty acid derivatives
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
MY130110A (en) 6-substituted mycophenolic acid and derivatives
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE296098T1 (de) Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose
BR9814048A (pt) "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "
EP0303681A4 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
ZA874198B (en) D-fenfluramine for use in the treatment of depression
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
RU2038102C1 (ru) Способ лечения вибрационной болезни
DE69510933D1 (de) Amidderivate und ihre therapeutische anwendung
NZ268039A (en) Use of efaroxan in treating parkinson's disease
NZ328915A (en) use of sulbutiamine to treat psychomotor and psychointellectual disorders
FR2749509B1 (fr) Procede de preparation d'une pate de soin epilatoire de maniere progressivement definitive avec effet de massage, desincrustante et astringente, hemostatique et apaisante
UA6490A (uk) Пристрій для поверхневої рефлексоголкотерапії "сената"
RU94034142A (ru) Способ немедикаментозного лечения больных с психологическо-вегетативными расстройствами

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties